1. bookVolume 49 (2015): Issue 1 (March 2015)
Journal Details
License
Format
Journal
First Published
30 Apr 2007
Publication timeframe
4 times per year
Languages
English
access type Open Access

Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer

Published Online: 03 Mar 2015
Page range: 59 - 64
Received: 19 Jan 2014
Accepted: 21 Mar 2014
Journal Details
License
Format
Journal
First Published
30 Apr 2007
Publication timeframe
4 times per year
Languages
English
Abstract

Background. Gastroesophageal reflux is suspected to be an etiological factor in laryngeal and pharyngeal cancer. The aim of this study was to establish, using a non-invasive method, whether laryngopharyngeal reflux (LPR) appears more often in patients with early laryngeal cancer than in a control group.

Patients and methods. We compared the pH, the level of bile acids, the total pepsin and the pepsin enzymatic activity in saliva in a group of 30 patients with T1 laryngeal carcinoma and a group of 34 healthy volunteers.

Results. The groups differed significantly in terms of levels of total pepsin and bile acids in the saliva sample. Higher levels of total pepsin and bile acids were detected in the group of cancer patients. No significant impact of other known factors influencing laryngeal mucosa (e.g. smoking, alcohol consumption, and the presence of irritating substances in the workplace) on the results of saliva analysis was found.

Conclusions. A higher level of typical components of LPR in the saliva of patients with early laryngeal cancer than in the controls suggests the possibility that LPR, especially biliary reflux, has a role in the development of laryngeal carcinoma.

Keywords

1. Koufman JA, Dettmar PW, Johnston N. Laryngopharyngeal reflux (LPR). ENT News 2005; 14: 42-5.Search in Google Scholar

2. De Corso E, Baroni S, Agostino S, Cammarota G, Mascagna G, Mannocci A, et al. Bile acids and total bilirubin detection in saliva of patients submitted to gastric surgery and in particular to subtotal billroth II resection. Ann Surg 2007; 245: 880-5.10.1097/01.sla.0000255574.22821.a1Search in Google Scholar

3. Tae K, Jin BJ, Ji YB, Jeong JH, Cho SH. The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: A preliminar report. Clin Exp Otorhinolaryngol 2011; 4: 101-4.10.3342/ceo.2011.4.2.101Search in Google Scholar

4. Dagli S, Dagli U, Kurtaran H, Alkim C, Sahin B. Laryngopharyngeal reflux in laryngeal cancer. Turk J Gastroenterol 2004; 15: 77-81.Search in Google Scholar

5. Lewin JS, GillenwaterAM, Garret JD. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer 2003; 97: 1010-4.10.1002/cncr.11158Search in Google Scholar

6. Galli J, Cammarota G, Volante M, De Corso E, Almadori G, PaludettiG. Laryngeal carcinoma and laryngo-pharyngeal reflux disease. Acta Otorhinolaryngol Ital 2006; 26: 260-3.Search in Google Scholar

7. Quadeer MA, Lopez R, Wood BG. Does acid suppresive therapy reduce the risk of laryngeal cancer recurrence? Laryngoscope 2005; 115: 1877-81.Search in Google Scholar

8. Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF Mathus- Vliegen LM. High incidence of laryngeal reflux in patients with head and neck cancer. Laryngoscope 2000; 110: 1007-11.10.1097/00005537-200006000-00023Search in Google Scholar

9. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux Symptom Index (RSI). J Voice 2002; 16: 274-7.10.1016/S0892-1997(02)00097-8Search in Google Scholar

10. Samuels TL, Johnston N. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngol 2010; 119: 203-8.10.1177/000348941011900310Search in Google Scholar

11. Knight J, Liveloy MO, Johnston N, Dettmar PW, Koufman JA. Sensitive Pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 2005; 115: 1473-8.10.1097/01.mlg.0000172043.51871.d9Search in Google Scholar

12. Buyukasik O, Hasdemir AO, Gulnerman Y, Col C, Ikiz O. Second primary cancers in patients with gastric cancer. Radiol Oncol 2010; 44: 239-43.10.2478/v10019-010-0048-2Search in Google Scholar

13. La Vecchia C, Zhang ZF, Altieri A. Alcohol and laryngeal cancer: an update. Eur J Cancer Prev 2008; 17: 116-24.10.1097/CEJ.0b013e3282b6fd40Search in Google Scholar

14. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates IN, et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottic and glottic in Central Europe. Am J Epidemiol 2007; 165: 814-20.10.1093/aje/kwk066Search in Google Scholar

15. Elci OC, Akpinar-Elci M. Occupational exposures and laryngeal cancer among non-smoking and non-drinking men. Int J Occup Environ Health 2009; 15: 370-3.10.1179/oeh.2009.15.4.370Search in Google Scholar

16. Peszynska-Piorun M, Malicki J, Golusinski W. Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT. Radiol Oncol 2012; 46: 328-36.10.2478/v10019-012-0050-ySearch in Google Scholar

17. Vitale GC, Cheadle WG, Patel B, Sadek Sa, Michel ME, Cusechieri A. The effect of alcohol on nocturnal gastroesophagealrefluks. JAMA 1987; 16: 258: 2077-9.10.1001/jama.1987.03400150069031Search in Google Scholar

18. Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L, et al. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol 2014; 48: 1-10.10.2478/raon-2013-0057Search in Google Scholar

19. Saruc M, Aksoy EA, Vardereli E, Karaaslan M, Cicek B, Ince U et all. Risk factors for laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2012; 269: 1189-96.10.1007/s00405-011-1905-3Search in Google Scholar

20. Phua SY. McGarvey L, Ngu M, Ing A. The differential effect of gastroesophageal reflux disease on mechanostimulation and chemostimulation of the laryngopharynx. Chest 2010; 138: 180-5. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo